ArticleCurrent developments in nutrition2018
Substitution of Corn Starch with Resistant Starch Type 4 in a Breakfast Bar Decreases Postprandial Glucose and Insulin Responses: A Randomized, Controlled, Crossover Study.
Article in Current developments in nutrition, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03239288 (A Randomized, Controlled, Crossover Study to Assess the Glucose and Insulin Excursions of a Test Fiber), which is not on this map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomized, Controlled, Crossover Study to Assess the Glucose and Insulin Excursions of a Test Fiber
Who cites it
10 citing papers in PubMed, 21 citations in OpenAlex.
- Engineering Slowly Digestible Starch via Physical and Enzymatic Modification: Structural Mechanisms of Formation.Comprehensive reviews in food science and food safety · 2026Review
- Dietary Polysaccharides and the Regulation of Blood Glucose and Lipid Parameters-A Narrative Review.Nutrients · 2026Review
- Starch, gallic acid, their inclusion complex and their effects in diabetes and other diseases-A review.Food science & nutrition · 2023Review
- Glycemic and Insulinemic Responses of Healthy Humans to a Nutrition Bar with or without Added FibersymInternational journal of environmental research and public health · 2022Article
- Research Progress on Hypoglycemic Mechanisms of Resistant Starch: A Review.Molecules (Basel, Switzerland) · 2022Review
- Resistant starch type-4 intake alters circulating bile acids in human subjects.Frontiers in nutrition · 2022Article
- Resistant Starch Combined with Whey Protein Increases Postprandial Metabolism and Lowers Glucose and Insulin Responses in Healthy Adult Men.Foods (Basel, Switzerland) · 2021Article
- Metabolic Responses to Native Wheat Starch (MidsolCurrent developments in nutrition · 2021Article
- Nutritional Bar with Potato-Based Resistant Starch Attenuated Post-Prandial Glucose and Insulin Response in Healthy Adults.Foods (Basel, Switzerland) · 2020Article
- Novel Resistant Starch Type 4 Products of Different Starch Origins, Production Methods, and Amounts Are Not Equally Fermented when Fed to Sprague-Dawley Rats.Molecular nutrition & food research · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundResistant starches type 4 (RS4) are chemically modified starches that are resistant to digestion by human enzymes.
objectiveWe aimed to test our hypothesis that replacement of standard starch with RS4 in a baked breakfast bar would decrease postprandial glycemic and insulinemic responses in healthy adults.
methodsIn this double-blind, randomized crossover study, 21 healthy adults [10 men; 20-45 y old; BMI (kg/m
resultsMedian glucose iAUC
conclusionThe results suggest that replacement of standard starch with tapioca-based RS4 is a practical approach for reducing available carbohydrate in products and achieving postprandial blood glucose management. This trial was registered at clinicaltrials.gov as NCT03239288.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.